Διεθνές συνέδριο για τις εξελίξεις στον τομέα της Εργαστηριακής Διαγνωστικής

05/09/18 – 1min. read

Όµιλος ΒΙΟΙΑΤΡΙΚΗ διοργάνωσε µε επιτυχία το διεθνές συνέδριο για τις εξελίξεις στον τοµέα της Εργαστηριακής ∆ιαγνωστικής, Athena Society, από τις 5 έως τις 8 Σεπτεµβρίου στο Grecotel Corfu Imperial.

Καθηγητές πανεπιστηµίων  και διακεκριµένοι επιστήµονες από όλο τον κόσµο παρευρέθηκαν και παρουσίασαν τις τρέχουσες επιστηµονικές εξελίξεις στον τοµέα.

Το συνέδριο αυτό πραγµατοποιείται από το 1994 στην Ελλάδα κάθε 3 χρόνια. Ενδεικτικά το επιστηµονικό πρόγραµµα του συνεδρίου:

Pathology Data Base Mining – T. Badrick, Royal College
of Pathologists AU 

What’s wrong with LOINC and aggregated lab data?
– G. Miller, Virginia Commonwealth University

What is blockchain and what is its role in healthcare?
– S. Haymond, Lurie Children’s Hospital, Chicago, IL

Towards the use of circulating DNA for cancer screening
– D. Lo, Chinese Univ.  Hong Kong

Syndromic infectious disease testing: time as the bottleneck for effective point-of-care – C. Wittwer, Univ. of Utah

Non Invasive Prenatal Testing (NIPT) of Fetal Chromosomal Disorders: implementation in routine prenatal care
– V. Velissariou, Bioiatriki SA

Expanding NIPT applications through understanding the biology of circulating fetal DNA – R. Chiu, Chinese U. Hong Kong

 Who or what is SHERLOCK?
– A. Gronowski, Washington Univ.

 Beyond genetic testing: Clandestine uses of DNA
– G. Bodor, Univ. Colorado

Breath, Sweat and Tears
– M. Cervinski, Dartmouth-Hitchcock Med Center

Mini, mighty and mature:
 The future state of clinical mass spectrometry
– M. DeMarco, Univ. British Columbia

A multi-omics approach to diagnostics – C.A. Burnham, Washington U. School of Medicine

Bug or Virus: Can the host response provide the answer? – S. Evans, BioDecisions Consulting

Precision Medicine in Oncology: a critical role
of the lab – O. Laterza, Merck

Will Continuous Glucose Monitoring happen in intensive care settings
– M. Scott, Washington Univ.

Novel Testing for Cardiac Injury: Can We Improve Beyond Cardiac Troponin
– F. Apple, Univ. of Minnesota

Regulatory approvals using real world data. A modern twist on curate’s egg
– C. Fantz, Roche Diagnostics

New paradigms of medical education – A. Saenger, Univ. of Minnesota

Scientific publishing in the 21st Century: challenges and trends – N. Rifai, Boston Children’s Hosp

Formation of The WHO Essential Diagnostics List
– L. Schroeder, Univ. Michigan

Innovative Diagnostics for the Developing World – S. Riley

Will drones revolutionize medical sample delivery?
 T. Amukele, Johns Hopkins


Personal utility and value-based pricing in laboratory medicine – P. Bossuyt, University of Amsterdam

Brave or Not, the Direct-to-Consumer Genetic Testing World is Here. What’s the Current Landscape?
– D. Grenache, TriCore Laboratories

XPRIZE Tricorders and Point-of-Consumer Blood Diagnostics:  Where are we now? – E. Chan, DNA Medicine Institute

Predicting the impact of a whole exome sequencing at the time of birth on current laboratory testing
– E. Ashwood, Univ. Colorado